From the CEO’s Desk
A note from Kathleen Brunner

We are pleased to present the inaugural edition of the Nucleus newsletter, dedicated to the latest developments in intelligent digital transformation for the life sciences industry. As a leading provider of cutting-edge solutions, we are committed to bringing our clients the most advanced tools and techniques to keep them at the forefront of this rapidly evolving industry.

We firmly believe that intelligent digital transformation can be a powerful tool in driving innovation and improving outcomes in the life sciences. Our team of highly skilled professionals brings together a unique blend of expertise in technology, life sciences, and business strategy to deliver results that are truly transformative.

Over the past year, we have been working tirelessly to develop new products and services that address some of the most pressing challenges facing life sciences professionals today. Our focus on intelligent digital transformation has allowed us to leverage the latest tools and techniques, from advanced analytics to machine learning and artificial intelligence, to help our clients overcome obstacles and achieve their goals.

With decades of experience working with some of the most innovative companies in the industry, we understand the challenges facing our clients and are dedicated to helping them achieve their objectives. Our commitment to intelligent digital transformation is unwavering, and we are confident that together, we can make a meaningful difference in the lives of people around the world.

Looking ahead, we are excited to continue pushing the boundaries of what is possible in the life sciences industry. We remain committed to our mission of helping our clients achieve their goals through the power of intelligent digital transformation, and we are confident that together, we can drive innovation and create a better future for all.

Thank you for your continued support and partnership. We look forward to sharing more updates and insights with you in the future.We’re just a click away with two easy ways to stay in touch.
Contact us here to make this a two-way conversation
Follow us on LinkedIn

What’s happening at Acumen? We launched a podcast!
Life Sphere launched in May of 2022 and is currently in its second season. We have an esteemed line up of women leaders in Life Science sharing their stories and perspective on the challenges and opportunities facing the industry. If you are an executive woman in Life Sciences with a story to tell, we want to share it with on Life Sphere audience. Get in touch!

Life Sphere NewsLetter Image

Listen to Life SphereCollaborate
New Partnership Alert
Acumen is thrilled to announce we have recently become a UiPath partner. UiPath is a leading global software company that makes Robotic Process Automation (RPA) software. As a trusted UiPath partner, Acumen can better meet the growing demand for RPA. We can now offer joint solutions that will accelerate our customers’ digital transformation, helping them transform and scale their business. Under the vision of our CEO, Kathleen Brunner, Acumen has developed an RPA offering that will meet the needs of our customers and change the way they do business taking them from manual to digital with speed and efficiency.

UiPath_Partner_Logo

Innovate 
Top 8 That Innovate
We are thrilled to announce that Acumen was selected by the Diversity Alliance for Science (DA4S) as one of the TOP EIGHT (Eight that Innovate) for our Digital Validation offering. Our innovative solution was recognized by DA4S, a leading organization dedicated to promoting diversity and inclusion in the life sciences industry. Acumen CEO, Kathleen Brunner presented our offering with a short video at the DA4S East Coast Conference. We were honored to be selected and look forward to continuing to provide our clients with innovative solutions to achieve their business goals.

Acumen_is_honored_to_be_selected_in small

Titan 100
We’re so excited to announce that our very own Kathleen Brunner has been selected as a distinguished honoree for the Philadelphia TITAN 100! This prestigious recognition is a testament to Kathleen’s exemplary leadership and unwavering dedication to Acumen’s success. We extend our heartfelt congratulations to Kathleen and also celebrate the achievements of all the remarkable individuals honored as part of the Titan 100 . Together, we inspire and drive excellence in the Philadelphia business community.

X2023_Philadelphia_Titan_100_Billboa

Best Place to Work
We are honored to be named among the Best Places to Work in Greater Philadelphia. This recognition reaffirms our commitment to fostering an exceptional work environment. Our talented team’s dedication and passion have made this achievement possible, and we grateful for the work they do. We remain committed to continuous improvement and creating a workplace that nurtures growth and collaboration. Together, we contribute to the thriving professional landscape of Greater Philadelphia. We are honored and thrilled as we look forward to the exciting opportunities ahead.

Accelerate 
Patent Pending ValiGenius
Our technology-enabled ValiGenius is cost-effective, scalable and flexible, offering rapid validation services that minimize the time-to-market for new products and services. Our automated validation process for SaaS applications ensures accuracy and reliability of data production. Continuous support is provided for software validation, including updates, upgrades and re-validation as needed. This ensures ongoing regulatory compliance and reduced risk of data loss and security breaches in SaaS applications used in GXP.

ValiGenius

Transform
What We’re ReadingMethodology to Define a Pharma 4.0™ Roadmap 
Learn how the Pharma 4.0™ framework and a data-centric approach can revolutionize the biopharma industry by enabling digitalization, data integrity and process optimization.Women in Pharma® Editorial: Industry Growth Generates Opportunity & Diverse Workforce 
Discover how the thriving pharmaceutical industry in the Germany/Austria/Switzerland region has created opportunities for women, fostered diversity, and driven advancements in research, development, and regulatory frameworks.

Get in touch with us!